141 related articles for article (PubMed ID: 36844198)
21. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
[TBL] [Abstract][Full Text] [Related]
22. Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resection.
Lee SH; Min JW; Lee JS; Kim CH; Yoo YD; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
Lung Cancer; 2015 Jan; 87(1):45-52. PubMed ID: 25468147
[TBL] [Abstract][Full Text] [Related]
23. The Mitochondrial-Derived Peptide MOTS-c Attenuates Oxidative Stress Injury and the Inflammatory Response of H9c2 Cells Through the Nrf2/ARE and NF-κB Pathways.
Shen C; Wang J; Feng M; Peng J; Du X; Chu H; Chen X
Cardiovasc Eng Technol; 2022 Oct; 13(5):651-661. PubMed ID: 34859377
[TBL] [Abstract][Full Text] [Related]
24. Plasma mitochondrial derived peptides MOTS-c and SHLP2 positively associate with android and liver fat in people without diabetes.
Sequeira IR; Woodhead JST; Chan A; D'Souza RF; Wan J; Hollingsworth KG; Plank LD; Cohen P; Poppitt SD; Merry TL
Biochim Biophys Acta Gen Subj; 2021 Nov; 1865(11):129991. PubMed ID: 34419510
[TBL] [Abstract][Full Text] [Related]
25. Exercise-induced desaturation in patients with chronic obstructive pulmonary disease on six-minute walk test.
Dogra AC; Gupta U; Sarkar M; Padam A
Lung India; 2015; 32(4):320-5. PubMed ID: 26180379
[TBL] [Abstract][Full Text] [Related]
26. Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities.
Perez T; Deslée G; Burgel PR; Caillaud D; Le Rouzic O; Zysman M; Escamilla R; Jebrak G; Chanez P; Court-Fortune I; Brinchault-Rabin G; Nesme-Meyer P; Paillasseur JL; Roche N;
Int J Chron Obstruct Pulmon Dis; 2019; 14():1399-1410. PubMed ID: 31308646
[No Abstract] [Full Text] [Related]
27. Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.
Lee SH; Choi SI; Lee JS; Kim CH; Jung WJ; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
Cancer Res Treat; 2017 Jan; 49(1):141-149. PubMed ID: 27188201
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of reactive oxygen species modulator 1 is associated with advanced grades of bladder cancer.
Ghasemi H; Amini MA; Pegah A; Azizi E; Tayebinia H; Khanverdilou S; Mousavibahar SH; Alizamir A
Mol Biol Rep; 2020 Sep; 47(9):6497-6505. PubMed ID: 32770525
[TBL] [Abstract][Full Text] [Related]
29. The Relationship between Exertional Desaturation and Pulmonary Function, Exercise Capacity, or Medical Costs in Chronic Obstructive Pulmonary Disease Patients.
Tsai ML; Li CL; Chang HC; Tsai YC; Tseng CW; Liu SF
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837592
[No Abstract] [Full Text] [Related]
30. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
de Moraes MR; da Costa AC; Corrêa Kde S; Junqueira-Kipnis AP; Rabahi MF
Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
[TBL] [Abstract][Full Text] [Related]
32. Cross-Sectional Study of Chronic Obstructive Pulmonary Disease Prevalence Among Smokers, Ex-Smokers, and Never-Smokers in Almaty, Kazakhstan: Study Protocol.
Sharman A; Zhussupov B; Sharman D; Stambekova A; Yeraliyev S
JMIR Res Protoc; 2017 Jul; 6(7):e143. PubMed ID: 28743683
[TBL] [Abstract][Full Text] [Related]
33. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
[TBL] [Abstract][Full Text] [Related]
34. Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD.
Du Plessis JP; Fernandes S; Jamal R; Camp P; Johannson K; Schaeffer M; Wilcox PG; Guenette JA; Ryerson CJ
Respirology; 2018 Apr; 23(4):392-398. PubMed ID: 29193512
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Serum Humanin and MOTS-c Peptide Levels in Patients with COVID-19 and Healthy Subjects.
Saracaloglu A; Mete AÖ; Ucar DF; Demiryürek S; Erbagcı E; Demiryürek AT
Curr Protein Pept Sci; 2023; 24(3):277-283. PubMed ID: 36799414
[TBL] [Abstract][Full Text] [Related]
36. Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study.
Kong M; Sung JY; Lee SH
Onco Targets Ther; 2019; 12():8263-8273. PubMed ID: 31632076
[TBL] [Abstract][Full Text] [Related]
37. Dynamic hyperinflation, arterial blood oxygen, and airway oxidative stress in stable patients with COPD.
García-Rio F; Romero D; Lores V; Casitas R; Hernanz A; Galera R; Alvarez-Sala R; Torres I
Chest; 2011 Oct; 140(4):961-969. PubMed ID: 21436248
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patients.
Kim HJ; Jo MJ; Kim BR; Kim JL; Jeong YA; Na YJ; Park SH; Lee SY; Lee DH; Kim BH; Yoo YD; Oh SC
Onco Targets Ther; 2018; 11():4233-4246. PubMed ID: 30087567
[TBL] [Abstract][Full Text] [Related]
39. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?
Rahman I; Swarska E; Henry M; Stolk J; MacNee W
Thorax; 2000 Mar; 55(3):189-93. PubMed ID: 10679536
[TBL] [Abstract][Full Text] [Related]
40. Impact of Radiation Therapy on Serum Humanin and MOTS-c Levels in Patients with Lung or Breast Cancer.
Kavak AG; Karslioglu I; Saracaloglu A; Demiryürek S; Demiryürek AT
Curr Radiopharm; 2024 Jan; ():. PubMed ID: 38314601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
